Chinese consensus on early diagnosis of primary lung cancer (2014 version)

Cancer

Volumn 121, Issue S17, 2015, Pages 3157-3164

  Hu, Jie ^a   Qian, Gui Sheng ^b   Bai, Chun Xue ^a,c  

^a FUDAN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

bronchoscopy; diagnosis; lung cancer; screening

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; PROGASTRIN RELEASING PEPTIDE;

AIR POLLUTION; ARTICLE; BRONCHOSCOPY; CANCER GRADING; CHINESE; CHRONIC LUNG DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FAMILY HISTORY; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; LUNG CANCER; LUNG NODULE; MEDIASTINOSCOPY; MEDICAL INFORMATION; MINIMALLY INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; PLEURA BIOPSY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPUTUM CYTODIAGNOSIS; SYMPTOMATOLOGY; THORACOCENTESIS; THORACOSCOPY; THORAX RADIOGRAPHY; ULTRASOUND; ADVERSE EFFECTS; CHINA; COMPLICATION; LUNG NEOPLASMS; MASS SCREENING; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

BRONCHOSCOPY; CHINA; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 84940704254     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29571     Document Type: Article

References (21)

1. Bender E,. Epidemiology: The dominant malignancy. Nature. 2014; 513 (7517): S2-S3.
2. Lin BQ, Peto R, Chen ZM, et al., Emerging tabacco hazards in China:Retrospective proportional mortality study of one million deaths. BMJ. 1998; 317 (7170): 1411-1422.
3. Bai CX,. The current status and controversy of lung cancer screening. In:, Wang C, ed. Respiratory and Intensive Medical Care. Beijing, China: People's Medical Publishing; 2012: 455-459.
4. Bai CX,. Three plus two diagnoses method for lung nodules. Int J Respir. 2013; 33 (6): 401-402.
5. Jemal A, Thun MJ, Ries LA, et al., Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008; 100: 1672-1694.
6. Moolgavkar SH, Holford TR, Levy DT, et al., Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst. 2012; 104: 541-548.
7. Lubin JH, Boice JD Jr,. Lung cancer risk from residential radon: meta-analysis of 8 epidemiologic studies. J Natl Cancer Inst. 1997; 89: 49-57.
8. Darby S, Hill D, Auvinen A, et al., Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies [serial online]. BMJ. 2005; 330: 223.
9. Matakidou A, Eisen T, Houlston RS,. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005; 93: 825-833.
10. Mayne ST, Buenconsejo J, Janerich DT,. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999; 149: 13-20.
11. Skillrud DM, Offord KP, Miller RD,. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986; 105: 503-507.
12. Koshiol J, Rotunno M, Consonni D, et al., Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study [serial online]. PLoS One. 2009; 4: e7380.
13. Turner MC, Chen Y, Krewski D, et al., Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007; 176: 285-290.
14. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening, Version 1.2016. Fort Washington, PA: NCCN; 2016 version 1. Available at: http://www.nccn.org/professionals/physician-gls/pdf/lung-screening.pdf
15. Zhi XY, Wu YL, Bu H, et al., Lung Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health. Chinese guidelines on the diagnosis and treatment of primary lung cancer. J Thorac Dis. 2012; 4: 88-101.
16. Wender R, Fontham ET, Barrera E Jr, et al., American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013; 63: 106-117.
17. Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E,; ESMO Guidelines Working Group. Metastatic nonsmall-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 (suppl 7): vii56-vii64.
18. Field JK, Smith RA, Aberle DR, et al., IASLC CT Screening Workshop 2011 Participants. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol. 2012; 7: 10-19.
19. Klabunde CN, Marcus PM, Han PK, et al., Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med. 2012; 10: 102-110.
20. Nair A, Hansell DM,. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol. 2011; 21: 2445-2454.
21. Lung Cancer Study Group of the Chinese Thoracic Society and the Chinese Alliance Against Lung Cancer Expert Group. Chinese consensus on diagnose of lung nodules. Zhonghua Jie He He Hu Xi Za Zhi. 2015; 38 (4): 249-254.